Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

Volume 3, Issue 9, Page 9 (September 2007)


View previous. 11 of 30 View next.

PREVIEW

FULL TEXT

FULL-TEXT PDF (61 KB)

CITATION ALERT

CITED BY

EXPORT CITATION

EMAIL TO A COLLEAGUE

RIGHTS/PERMISSIONS

NEED REPRINTS?

Alzheimer Drugs Need Priority Review

MICHELE G. SULLIVAN (Mid-Atlantic Bureau)

Drugs for Alzheimer disease are significantly less likely than cancer or HIV drugs to receive priority review from the Food and Drug Administration, according to a new study.

PII: S1553-3212(07)70268-6

doi:10.1016/S1553-3212(07)70268-6


View previous. 11 of 30 View next.

Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.